Tevogen Bio Holdings Inc.
TVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $153,941 | $230,384 | $174,320 | $183,331 |
| - Cash | $1,037 | $685 | $1,975 | $1,283 |
| + Debt | $3,129 | $7,556 | $4,822 | $2,886 |
| Enterprise Value | $156,034 | $237,255 | $177,167 | $184,934 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$27 | -$291 | -$105 | -$104 |
| % Margin | – | – | – | – |
| EBITDA | -$5,637 | -$5,175 | -$10,237 | -$9,325 |
| % Margin | – | – | – | – |
| Net Income | -$5,727 | -$5,504 | -$10,367 | -$9,250 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.03 | -0.031 | -0.065 | -0.052 |
| % Growth | 2% | 53% | -25.2% | – |
| Operating Cash Flow | -$3,650 | -$3,190 | -$3,308 | -$3,048 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3,650 | -$3,190 | -$3,308 | -$3,048 |